West Island Brands Inc (WIBFF) Fair Value & Analysis
Healthcare · US · Market cap $60.1K
West Island Brands Inc
WIBFF · US
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.0037 to $0.0035 (−6.1%) since Jun 25, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0035 – $0.0035 · fair‑value band $0.0035 – $0.0035 · the $0.0035 price screens above the $0.0035 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
West Island Brands Inc (WIBFF) currently trades at $0.0035, while our model-based Fair Value estimate is $0.0035 — implying the stock looks roughly 0.7% overvalued today. We read business quality at 46/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, West Island Brands Inc generated revenue of $4.7M at a net margin of -94.1%. Revenue grew 163.3% year over year. It earns a return on equity of -99.6%. Net debt stands at $1.5M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
West Island Brands Inc. operates as a cannabis company in Canada. It offers its products under the OUEST, CITOYEN, and Silk Road brand names. The company was formerly known as Matica Enterprises Inc. and changed its name to West Island Brands Inc. in October 2021. West Island Brands Inc. was incorporated in 2007 and is based in Toronto, Canada.
Revenue & earnings trend
FY2017 – FY2021 · reported fiscal years
West Island Brands Inc reported revenue of $2.3M in FY2021 versus $0 in FY2017. Reported net income was −$5.1M in FY2021.
Is WIBFF fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,782 | ₹915.92 | -49% |
| Zoetis Inc Z1TS34 | R$24.45 | R$6.33 | -74% |
| Hansoh Pharmaceutical Group 3692 | HK$29.32 | HK$23.94 | -18% |
| Divi's Laboratories Limited DIVISLAB | ₹6,623 | ₹1,461 | -78% |
| Swedish Orphan Biovitrum AB SOBI | kr 444.80 | kr 440.64 | -1% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is West Island Brands Inc (WIBFF) undervalued?
What is the fair value of WIBFF?
What is the quality score of WIBFF?
What is the revenue of West Island Brands Inc (WIBFF)?
What is the net profit margin of WIBFF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.